Clinical trial
Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult Subjects
NCT00499538 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00499538 |
|---|---|
| Title | Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult Subjects |
| Official title | A Single Dose Bioavailability Study of 3 New Formulations of SKI-606 (500 mg) Compared With a Reference Capsule and an Oral Solution in Healthy Adult Subjects |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | SKI-606 |
| Enrollment | 40 |
| Start date | Jul 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jul 11, 2007 |
| Last update posted | Dec 27, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: